Polyclinic University Hospital
Bari, BA, 70124, Italy
NCT Number: NCT07620106
To evaluate the prevalence of hospitalized patients who receive artificial nutrition, the type of patients who resort to artificial nutrition, the appropriateness of the latter in terms of specificity with respect to the clinical condition, and the adequacy of the caloric-protein intake provided to the patient.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Bari, BA, 70124, Italy
Despite detailed recommendations provided by international scientific societies, numerous studies highlight substantial variability and deficiencies in clinical practice, notably delays in initiating artificial nutrition (AN), inadequate caloric and protein dosing, and disparities in treatment across patient groups. Unfortunately, applying the general recommendations to nutritional therapy for polymorbid patients is particularly challenging for healthcare providers without specific nutrition training, as disease-specific quantitative and qualitative nutritional requirements must be considered. In this report, we present results obtained from data collected on hospitalized patients undergoing AN across 35 medical and surgical wards and the intensive care unit of a university hospital in Southern Italy. In all these cases, the decisions regarding the type (enteral/parenteral) and the intensity (calories/proteins) of the nutritional interventions observed were made by the physicians working on the wards. This study describes the application of AN in real-world hospital settings, identifying the main critical issues and suggesting possible interventions to improve clinical practice.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Hospitalized patients receiving artificial nutrition -
Exclusion criteria
Patients on normal oral feeding.
-
Time frame: Baseline evaluation was performed for all patients on the same day, which corresponded to a variable time from the beginning of hospitalization.
Among the 578 hospitalized patients, 56 (9.7%; 30 males, 26 females), with a mean age of 67.1 ± 11.6 years, were receiving artificial nutrition (AN). The modalities of AN administration were as follows: total parenteral nutrition (TPN) in 39 patients, enteral nutrition (EN) in 16 patients, and EN plus supplemental parenteral nutrition (SPN) in 1 patient.
Time frame: Baseline evaluation was performed for all patients on the same day, which corresponded to a variable time from the beginning of hospitalization.
The total caloric intake received by each patient was calculated based on the characteristics of nutritional parenteral and enteral products and the duration of their infusion. The appropriateness of the caloric intake was calculated using the most accurate prediction formula suggested for a specific body mass index (BMI) range.
Time frame: Baseline evaluation was performed for all patients on the same day, which corresponded to a variable time from the beginning of hospitalization.
Patients admitted to the intensive care unit were fed by enteral nutrition and received only 0.41 ± 0.15 g/kg b.w. Patients receiving parenteral nutrition had a protein intake ranging from 0.55 ± 0.15 to 0.70 ± 0.17 g/kg of body weight.
Time frame: This evaluation was performed at baseline
The median time to initiate AN following hospital admission was 3 days (IQR 0-13.5 days). In detail, ICU patients received AN after 1 day (IQR 0-2), whereas patients in other wards received saline solutions with or without glucose for 5 days (IQR 0-16) after admission before commencing AN.
University of Bari
Other
Nutrition Day: Prevalenza Della Nutrizione Artificiale Nei Pazienti Ospedalizzati e Appropriatezza Prescrittiva a Supporto Della Valutazione Dei Costi e Della Programmazione Dei Consumi.
Acronym: COCONUT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06737211
Bowel Ischemia, Colonic Diseases
Athens, Greece
View Trial DetailsNCT01943409
Bites and Stings, Cancer
Toronto, Ontario, Canada
View Trial DetailsNCT06573632
Hyperphagia, Major Surgery
Kathmandu, Bagmati, Nepal
View Trial DetailsNCT02987569
Digestive System Diseases, Gastrointestinal Diseases
Kansas City, Kansas, United States
View Trial Details